Amphotericin B Unknown Status Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) Prevention

IndicationsStatusPurposePhase
Unknown StatusPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00451711Intermittent Liposomal Amphotericin B Primary Prophylaxis